Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02268357
Other study ID # NL42210.018.13
Secondary ID
Status Completed
Phase Phase 2/Phase 3
First received
Last updated
Start date November 2014
Est. completion date December 2018

Study information

Verified date April 2020
Source Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Randomized, placebo-controlled, double-blind, parallel group clinical trial evaluating the anxiolytic effects of propranolol on fear of wisdom tooth removal. It is hypothesized that, compared to placebo, perioperative oral propranolol reduces dental trait anxiety at 1 month follow-up after wisdom tooth removal.


Description:

RATIONALE Tooth and molar removals are among the most feared interventions in dentistry and oral and maxillofacial surgery (OMFS). Anxiety for these procedures not only produces discomfort to the patient, but may also induce patient behavior that impedes surgery, thereby increasing operative time and complicating postoperative recovery. In addition, it has been found that having undergone an extraction poses a significantly increased risk for developing chronic apprehension for dental surgical procedures, disproportionate forms of dental anxiety (i.e., dental phobia), and symptoms of post-traumatic stress. Addressing these problems effectively requires an intervention that reduces both state anxiety during surgery and dental trait anxiety in the long term.

OBJECTIVE The purpose of this trial is to determine the anxiolytic effects of the ß-adrenoreceptor antagonist propranolol on patients with high levels of fear in anticipation of dental extraction.

METHODS Trial design: Randomized, placebo-controlled, two-group, parallel, double-blind, single center trial of 34 participants. Population and recruitment: Consecutive patients, referred by their dentist to the department of Oral and Maxillofacial Surgery of the Academic Medical Center of the University Amsterdam, for at least two tooth and/or molar removals, with self-reported high to extreme fear in anticipation of dental extraction. Intervention: Two 40 mg propranolol capsules one hour prior to dental extraction, followed by one 40 mg capsule directly postoperatively. Comparator: Placebo capsules. Primary outcome: Dental trait anxiety score reduction from baseline to 4-weeks follow-up. Secondary outcomes: Self-reported anxiety during surgery; physiological parameters (heart rate and blood pressure) during recall of the crucial fear-related memory; self-reported vividness and emotional charge of the crucial fear-related memory.

RISKS AND BENEFITS ASSOCIATED WITH PARTICIPATION Participants of the trial will undergo regular dental extraction procedures (treatment as usual), with an additional potentially anxiolytic pharmacological intervention (propranolol) or placebo. The most important known side-effects of propranolol are mild and self-limiting.


Recruitment information / eligibility

Status Completed
Enrollment 36
Est. completion date December 2018
Est. primary completion date December 2018
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion criteria

1. Signed written informed consent

2. = 18 Years of age on entry to the study

3. Self-reported high to extreme fear of tooth or molar removal

4. Dutch or English-speaking

Exclusion criteria

1. Asthma or other obstructive pulmonary disease

2. Cardiac failure

3. Cardiac arrhythmia

4. Renal failure

5. Insulin-dependent diabetes mellitus

6. Pregnant or breast-feeding

7. Current use of another ß-adrenoreceptor antagonist

8. Current use of anxiolytic or antidepressant medication

9. Currently in psychotherapy for dental anxiety

10. Systolic blood pressure < 100 mmHg

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Propranolol
Oral propranolol capsules

Locations

Country Name City State
Netherlands Dept. of Oral and Maxillofacial Surgery, Academic Medical Center, University of Amsterdam Amsterdam

Sponsors (1)

Lead Sponsor Collaborator
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Country where clinical trial is conducted

Netherlands, 

References & Publications (3)

Brunet A, Orr SP, Tremblay J, Robertson K, Nader K, Pitman RK. Effect of post-retrieval propranolol on psychophysiologic responding during subsequent script-driven traumatic imagery in post-traumatic stress disorder. J Psychiatr Res. 2008 May;42(6):503-6. Epub 2007 Jun 22. — View Citation

Liu HH, Milgrom P, Fiset L. Effect of a beta-adrenergic blocking agent on dental anxiety. J Dent Res. 1991 Sep;70(9):1306-8. — View Citation

Lonergan MH, Olivera-Figueroa LA, Pitman RK, Brunet A. Propranolol's effects on the consolidation and reconsolidation of long-term emotional memory in healthy participants: a meta-analysis. J Psychiatry Neurosci. 2013 Jul;38(4):222-31. doi: 10.1503/jpn.120111. Review. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Change from baseline at 1 month follow-up in Short version of the Dental Anxiety Inventory (S-DAI) dental trait anxiety Change from baseline at 1 month follow-up
Secondary Change from baseline at 1 month follow-up in Self-reported vividness and emotional charge of the crucial fear-related memory Visual analogue scale Change from Baseline at 1 month follow-up
Secondary Change from baseline at 1 month follow-up in State anxiety during treatment Visual analogue scale Change from Baseline at 1 month follow-up
Secondary Change from baseline at 1 month follow-up in Physiological parameters (heart rate and blood pressure) during recall of the crucial fear-related memory Change from Baseline at 1 month follow-up
See also
  Status Clinical Trial Phase
Completed NCT06385314 - A Cross Sectional Study on Dental Anxiety and State Anxiety Related to Removal of Fixed Partial Dentures
Completed NCT04308005 - Drawing as a Measurement of Dental Anxiety
Completed NCT01908127 - Efficacy of Film Modelling in Paediatric Dentistry N/A
Completed NCT00695630 - Flumazenil Reversal of Oral Triazolam Phase 1/Phase 2
Completed NCT05759286 - A Blend of Lavender-neroli Oils Aromatherapy and Music for Managing Anxiety in a Pediatric Patient N/A
Completed NCT04234737 - Efficacy of Hypnotherapy in Children With Dental Anxiety N/A
Completed NCT03838081 - Evaluation on the Anxiety of Third Molar Extraction N/A
Enrolling by invitation NCT06057090 - Do Therapy Dogs Improve Behavior and Reduce Anxiety in Pediatric Dental Patients? N/A
Not yet recruiting NCT04924452 - Er:YAG Laser Therapy in Combination With Behaviour Management Technique in Reducing Anxiety Among Paediatric Patients N/A
Completed NCT03596255 - Clinical Estimation of Dental Anxiety
Completed NCT03722771 - Influence of Lavender Oil on Vital Signs in Oral Surgery Patients N/A
Completed NCT05038540 - The Effect of Virtual Reality Glasses on Dental Anxiety Control N/A
Completed NCT03324347 - Dog-Assisted Therapy in Dentistry N/A
Not yet recruiting NCT06139640 - The Effect of Damask Rose Essential Oil Aromatherapy on Dental Anxiety and Pain on Children N/A
Completed NCT02591797 - Effectiveness of Hand/Eyes/Mouth Behavior Management Technique During Local Anesthesia in Preschool Children N/A
Completed NCT02588079 - Internet-Based Cognitive Behavioral Therapy for Children With Dental Anxiety N/A
Not yet recruiting NCT00355693 - Effect Site Controlled, Reaction Time Safeguarded, Patient Maintained Sedation With Propofol in Anxious Patients Phase 4
Recruiting NCT06243705 - Effectiveness of Robot-pets in Reducing Dental Anxiety in Children N/A
Recruiting NCT06058533 - Pre-Visit Positive Imagery in Reducing Dental Anxiety N/A
Completed NCT03993080 - Virtual Reality Relaxation to Decrease Dental Anxiety N/A